Gargoyle Investment Advisor Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molson Coors Class B
TAP
|
+$513K |
| 2 |
Biogen
BIIB
|
+$496K |
| 3 |
The Mosaic Company
MOS
|
+$493K |
| 4 |
Interactive Brokers
IBKR
|
+$474K |
| 5 |
AMC Global Media
AMCX
|
+$468K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eagle Materials
EXP
|
+$1.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$1.27M |
| 3 |
Goodyear
GT
|
+$1.24M |
| 4 |
Applied Materials
AMAT
|
+$1.15M |
| 5 |
Viatris
VTRS
|
+$1.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.62% |
| 2 | Financials | 16.9% |
| 3 | Consumer Discretionary | 13.2% |
| 4 | Industrials | 12.57% |
| 5 | Healthcare | 10.2% |
Similar funds
Gargoyle Investment Advisor's Q2 2019 Portfolio in Review
As of Q2 2019, Gargoyle Investment Advisor held 120 positions worth $90.1M, down 13% from $104M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Gargoyle Investment Advisor withdrew a net $14.3M in Q2 2019, closing 13 positions and reducing 31 holdings. Its most notable exit was Eagle Materials, an estimated $1.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Gargoyle Investment Advisor opened a new position in Biogen worth $502K.
- Gargoyle Investment Advisor's largest Q2 2019 buy was Biogen: 2,146 shares worth $502K.
- Gargoyle Investment Advisor added most to Molson Coors Class B in Q2 2019, an estimated $513K increase.
- Gargoyle Investment Advisor's biggest Q2 2019 reduction was Labcorp, cutting an estimated $861K.
- Gargoyle Investment Advisor fully exited Eagle Materials in Q2 2019, selling an estimated $1.4M.
- Gargoyle Investment Advisor's ten largest holdings make up 16% of its $90.1M portfolio in Q2 2019.
- Gargoyle Investment Advisor opened 6 new positions and closed 13 in Q2 2019.
- Gargoyle Investment Advisor's portfolio value fell 13% quarter-over-quarter to $90.1M.
Based on Gargoyle Investment Advisor's 13F filing for Q2 2019, filed 13 Aug 2019.